Literature DB >> 9492061

Osteoclasts from human giant cell tumors of bone lack estrogen receptors.

F M Collier1, W H Huang, W R Holloway, J M Hodge, M T Gillespie, L L Daniels, M H Zheng, G C Nicholson.   

Abstract

Although estrogen is important in human skeletal homeostasis, the major target cell in bone is unknown. Estrogen receptors (ER) have been demonstrated in osteoblasts and bone marrow stromal cells, but their presence in osteoclasts remains controversial because completely pure preparations have not been available. We have examined expression of ER-alpha and ER-beta messenger RNA (mRNA) by RT-PCR in samples from human giant cell tumor of bone (GCT), including: whole tumor, cultured mononuclear cells, and a pure osteoclast population obtained by microisolation. Whole tumor expressed both ER-alpha and calcitonin receptor (CTR) mRNA and apparently lower levels of ER-beta mRNA. Passaged cultures of tumor mononuclear stromal cells also expressed ER-alpha and low ER-beta but not CTR mRNA. In pure preparations of microisolated osteoclasts, expression of ER-alpha or ER-beta mRNA was not detected, whereas expression of CTR mRNA was readily identified. Microisolated GCT mononuclear cells expressed ER-alpha, but no detectable CTR mRNA. Fluorescence in situ hybridization (FISH) using an ER-alpha riboprobe demonstrated strong signal in the mononuclear cells but multinucleated osteoclasts showed no detectable signal. In contrast, CTR mRNA was detected in multinucleated osteoclasts but not in stromal-like tumor cells by FISH. 17Beta-estradiol consistently showed no effect on bone resorbing activity of osteoclasts from GCT cultured on cortical bone, although calcitonin was a potent inhibitor. These findings indicate that significant expression of ER does not occur in osteoclasts derived from human GCT and suggest that estrogen effects are mediated by other cells of the bone environment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492061     DOI: 10.1210/endo.139.3.5825

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.

Authors:  Ting Liu; Kavindra Nath; Weixia Liu; Rong Zhou; I-Wei Chen
Journal:  NMR Biomed       Date:  2015-07-14       Impact factor: 4.044

3.  Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells.

Authors:  H Sakai; S Jingushi; T Shuto; K Urabe; T Ikenoue; K Okazaki; T Kukita; A Kukita; Y Iwamoto
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

4.  Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.

Authors:  T Sunyer; J Lewis; P Collin-Osdoby; P Osdoby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 5.  Cross-species and interassay comparisons of phytoestrogen action.

Authors:  P L Whitten; H B Patisaul
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

Review 6.  Pulmonary metastasis of giant cell tumor of bones.

Authors:  Aikeremujiang Muheremu; Xiaohui Niu
Journal:  World J Surg Oncol       Date:  2014-08-20       Impact factor: 2.754

7.  Diagnosing giant cell tumor of the bone using positron emission tomography/computed tomography: A retrospective study of 20 patients from a single center.

Authors:  Aikeremujiang Muheremu; Yuan Ma; Zhen Huang; Huachao Shan; Yuan Li; Xiaohui Niu
Journal:  Oncol Lett       Date:  2017-06-14       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.